Compare SNTG & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNTG | ACON |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.5M |
| IPO Year | 2020 | 2022 |
| Metric | SNTG | ACON |
|---|---|---|
| Price | $1.72 | $1.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | ★ $7.63 |
| AVG Volume (30 Days) | 5.6K | ★ 13.6K |
| Earning Date | 12-18-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $75,730.00 |
| Revenue This Year | N/A | $44.55 |
| Revenue Next Year | N/A | $123.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 65.62 |
| 52 Week Low | $1.52 | $1.35 |
| 52 Week High | $2.86 | $9.36 |
| Indicator | SNTG | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 57.10 | 28.01 |
| Support Level | $1.65 | N/A |
| Resistance Level | $1.82 | $3.54 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 81.82 | 7.47 |
Sentage Holdings Inc is a financial service provider. The company offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.